Tiffany D Rau, Ph.D., Senior Consultant of BioProcess Technology Consultants, is an expert in bioprocessing and a Six Sigma Master Black Belt. Her international technical and managerial experience extends from development to post-commercial cGMP manufacturing. Dr. Rau has been instrumental in designing and leading initiatives to bring R&D and manufacturing together to increase speed to market and minimize technology transfer challenges. Dr. Rau has been the advisor on over 100 different projects in the areas of process intensification, scale-up, variability reduction, and continuous improvement for both microbial and mammalian expression systems Previously, Dr. Rau has held leadership positions at Evonik-Degussa, Eli Lilly, Pall and GlaxoSmithKline all focused in process development, tech transfer, and commercial manufacturing. Tiffany is currently on the Advisory Board of Vanderbilt University’s Chemical and Biomolecular Engineering Department as well as on Florida State’s and Florida A and M’s ChE Advisory Board. She is also an editor of the Journal of Industrial Microbiology and Biotechnology (JIMB).
Tiffany earned her Ph.D. in Chemical Engineering (ChE) from Vanderbilt University and received her B.S.E. in Chemical and Biomolecular Engineering from the University of Pennsylvania.